Sustained two-year treatment with tildrakizumab improved the psychological well-being of people with moderate to severe ...

Colorado became the first state in the nation to set a price cap on a specific medication last week, following a unanimous ...

A 16-week Mediterranean diet intervention significantly improved psoriasis severity and metabolic health in adults with mild to moderate psoriasis. The study demonstrated a notable reduction in ...

Meditation, biofeedback, aromatherapy, and other such therapies can relieve stress caused by psoriasis and fend off stress-triggered flares.

Obesity and the proinflammatory state are sufficiently tied to psoriasis and HS that GLP-1 agonists should be considered within multifaceted care, experts say.

A groundbreaking technology developed by Heriot-Watt University has received over £475,000 in funding to revolutionize how ...

A 16-week Mediterranean diet intervention significantly improves psoriasis severity in patients with mild-to-moderate disease receiving stable topical therapy.

The FDA approved a supplemental new drug application for Tremfya for the treatment of children aged 6 years or older with ...

Guselkumab is the first IL-23 inhibitor approved for pediatric plaque psoriasis and active psoriatic arthritis, addressing a significant treatment gap. The PROTOSTAR study showed 56% of children on ...

Novartis said it is launching a direct-to-patient platform in the U.S. to sell a discounted version of its Cosentyx drug, the latest big pharma company to move to cut prices ahead of the Trump ...

Psoriasis may not have a cure, but new research has found that significant relief could be achieved at the dinner table. In a ...

These extra skin cells pile up on the surface and form the red, scaly areas typical of the condition.